CLINICAL AND PARA-CLINICAL CHARACTERISTICS OF OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS) IN CHILDREN WITH TONSIL AND ADENOID HYPERTROPHY

Thị Quỳnh Anh Phí 1,, Hoa Phượng Đào1, Khánh Chi Lê1, Thị Hương Thảo Trần1, Thị Bảo Ngọc Bùi1, Thị Mai Loan Đinh 1, Thị Trà Giang Nguyễn1
1 Vietnam National Children's Hospital.

Main Article Content

Abstract

Background: Obstructive sleep apnea syndrome (OSAS) in children causes serious and longterm consequences, such as: retardation, disability in learning and remembering, depression, or hyperactivity, even sudden death. At least 80 percent of children with OSAS are unknown. We started this study with the specific aim: describing clinical and para-clinical features of children with hypertrophy of tonsil and/or adenoid. Methodology: This is an observation study on 114 OSAS children with hypertrophy of tonsil and/or adenoid at National hospital for children from June 2017 to August 2019. Result: The mean age was 5,5 years old. The oldest patient was 12 years old while the youngest one was 2.5 years old. Mean height was 113.9 cm; and mean weight was 22.7kg; mean BMI was 16,9kg/m2. The most common symptom was snoring (3,3thở miệng (2,7). Mean AHI was 12,6 ± 11.2 attacks per hour, classified as severe. Min SpO2 was 75.7 ± 13.7%. The most common symptom was snoring, observed OSAS attack, thở miệng, ngạt mũi. Mean AHI was 12,6 ± 11.2 attacks per hour, classified as severe. Combining chỉ số ngừng thở, giảm thở and SpO2 plays a key role in assessing OSAS severity and selecting treatment approaches. Conclusion: Among OSAS children with hypertrophy of tonsil and/or adenoid, the most common symptoms are snoring, sleep apnea, nasal obstruction, and mouth breathing. The mean AHI was 12.6±11.2 strikes/hour in severe level. The combination of apnea index, hypoventilation and blood oxygen saturation plays an important role in assessing the severity of the disease and choosing treatment methods.

Article Details

References

1. Marcus CL, B.S., Traylor J, et al, , Randomized double blind clinical trial of two different modes of positive airway pressure theraphy on adherence and efficacy in children. J Clin Sleep Med, 2012. 8(1): p. 37-42.
2. Lumeng JC, C.R., Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc, 2008. 5(2): p. 242-252.
3. Ahn, Y.M., Treatment of obstructive sleep apnea in children. Korean J Pediatric, 2010. 53(10): p. 872-879.
4. James Chan, J.C., Peter J. Koltai, Obstructive Sleep Apnea in Children. Am Fam Physician, 2004. 69 (5): p. 1147-1155.
5. Guilleminault, C., et al Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol Head Neck Surg, 2007. 136(2): p. 169-75.
6. Arens, R. and C.L. Marcus, Pathophysiology of upper airway obstruction: a developmental perspective. Sleep, 2004. 27(5): p. 997-1019.
7. Mitsuhiko Tagaya, et al, Relationship between adenoid size and severity of obstructive sleep apnea in preschool children, international Journal of peadiatric otorhinolaryngology, 2012, 76(12), p:1827-1830
8. Jing Wang, et al, Correlation between obstructive sleep apnea and adenotonsillar hypertrophy in children on different weight status, Scientific Reports , 2019, Article number 11455
9. Haya S.Alsubie và Ahmed S.BaHammam (2017). Obstructive Sleep Apnoea: Children are not little Adults. Paediatric Respiratory Reviews, 21, 72-79.
10. Leila Kheirandish-Gozal, Hari P. R. Bandla và and David Gozal (2016). Montelukast for Children with Obstructive Sleep Apnea: Results of a Double-Blind, Randomized, Placebo-Controlled Trial. Annals of the American Thoracic Society, 13 (10), 1736-1741.